# Atezolizumab and Bevacizumab in Combination With Y^90 Radioembolization in HCC for Liver Transplant

> clinical trial · VERIFIED · 2026-07-28

Status: RECRUITING · Sponsor: Icahn School of Medicine at Mount Sinai · Condition: Hepatocellular Carcinoma

- Company: Icahn School of Medicine at Mount Sinai
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT07059494

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.